Mechanistic Comparison# Dosing Comparison# Amycretin Dosing# Amycretin dosing is investigational: Subcutaneous: Once-weekly injection, doses up to 60 mg studied in phase 1b/2a over 36 weeks Oral: Daily tablet, doses up to 50 mg (or 2 x 50 mg) studied in phase 1 Phase 2 T2D: Both subcutaneous and oral formulations studied over 36 weeks Phase 3 dose selection will be informed by the completed phase 2 data
This comprehensive mechanism distinguishes it from single-peptide approaches and may explain enhanced healing responses observed in preliminary research models
Triptolide is a diterpene epoxy compound extracted from Tripterygium wilfordii, which is a highly effective Nrf2 inhibitor
doi: 10.3390/ijms20184472 Summary Keywords Glutathione, SARS-CoV-2, COVID-19, reactive oxygen species, oxidative stress, acute respiratory distress syndrome, atherosclerosis, atherothrombosis Citation Labarrere CA and Kassab GS (2022) Glutathione deficiency in the pathogenesis of SARS-CoV-2 infection and its effects upon the host immune response in severe COVID-19 disease
The 2-h post-last-ECT timing was specifically chosen as it allows for the assessment of cumulative effects of the complete ECT course on OS parameters, while minimizing potential confounding effects from other factors
These individuals in particular need extra methyl-folate